Filing metadata

Accession number
0001209191-21-049490
Form type
Form 3
Filer
Oyster Point Pharma, Inc.
CIK
CIK 1720725
Filed
Aug 03, 2021
Reporting period
Jul 30, 2021
Description
Initial ownership

Explore SEC Filings Hub